Therapy for glioma: Indian perspective

Indian Journal of Cancer

Volumn 46, Issue 2, 2009, Pages 127-131

  Munshi, A ^a   Jalali, R ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Central nervous system; Gliomas; Treatment

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; IRINOTECAN; LOMUSTINE; LONIDAMINE; NIMOTUZUMAB; PACLITAXEL; TEMOZOLOMIDE;

ANEMIA; ASTROCYTOMA; BRAIN TUMOR; CANCER EPIDEMIOLOGY; CANCER SURGERY; CANCER THERAPY; CLINICAL STUDY; CLINICAL TRIAL; CONFERENCE PAPER; GLIOBLASTOMA; GLIOMA; HUMAN; INDIA; LEUKOPENIA; MOLECULAR BIOLOGY; MULTIPLE CYCLE TREATMENT; QUALITY OF LIFE; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM NEOPLASMS; GLIOMA; HUMANS; INDIA; QUALITY OF LIFE; RADIOSURGERY; RADIOTHERAPY;

EID: 64749091217     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.49150     Document Type: Conference Paper

References (23)

1. Davis FG, Preston-Martin S, Bigner DD, McLendon RE, Bruner JM. Epiodemiology, Incidence and survival: Russell and Rubinstein's pathology of tumors of central nervous system. Arnold; 1999. p. 7.
2. Davis FG, Preston-Martin S, Bigner DD, McLendon RE, Bruner JM. Epiodemiology, Incidence and survival: Russell and Rubinstein's pathology of tumors of central nervous system. 1999.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
4. Tseng JH, Merchant E, Tseng MY. Effects of socioeconomic and geographic variations on survival for adult glioma in England and Wales. Surg Neurol 2006;66:258-63.
5. ICMR cancer registry: 2001-2003.
6. Sarkar C, Sharma MC, Deb P, Singh R, Santosh V, Shankar SK. Primary central nervous system lymphoma: A hospital based study of incidence and clinicopathological features from India (1980-2003). J Neurooncol 2005;71:199-204.
7. Jalali R, Datta D. Prospective analysis of incidence of central nervous tumors presenting in a tertiary cancer hospital from India. J Neurooncol 2008;87:111-4.
8. Wrensch M, Rice T, Miike R, McMillan A, Lamborn KR, Aldape K, et al. Diagnostic, treatment, and demographic factors infuencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro Oncol 2006;8:12-26
9. World population information 2007.
10. Suri V, Das P, Jain A, Sharma MC, Borkar SA, Suri A, et al. Neuro Oncol Pediatric glioblastomas: A histopathological and molecular genetic study. Neuro Oncol 2008 Dec 9. [Epub ahead of print]
11. Sarkar C, Sinha S, Sharma MC, Kumar R, Mehta VS. Supratentorial glioblastoma in adults: identifcation of subsets and their clinical correlation. Brain Tumor Pathol 2004;21:7-12
12. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
13. Jalali R, Basu A, Gupta T, Munshi A, Menon H, Sarin R, et al. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblas-toma multiforme: Single institution experience. Br J Neurosurg 2007;21:583-7.
14. Puri T, Goyal S, Sharma DN, Julka PK, Rath GK. Outcome of Gliob-lastoma Multiforme with adjuvant radiotherapy and chemotherapy: A single institution analysis AROI Proc 2008.
15. Kumar V, Rathi AK, Singh K, Mukherji A, Shekhar S, Bahadur AK. Study of factors predicting survival in patients with Glioblastoma multiforme treated with Concomitant radiation and Temozolomide AROI PROC 2008.
16. Casacó A, López G, García I, Rodríguez JA, Fernández R, Figueredo J, et al. Phase I single-dose study of intracavitary-administered nimotuzumab labeled with 188 Re in adult recurrent high-grade glioma. Cancer Biol Ther 2008;7:333-9.
17. Prabhakara S, Kalia VK. Optimizing radiotherapy of brain tumors by a combination of temozolomide and lonidamine. Indian J Med Res 2008;128:140-8.
18. Edwards MS, Wara WM, Urtasun RC, Prados M, Levin VA, Fulton D, et al. Hyperfractionated radiation therapy for brain-stem glioma: A phase I-II trial. J Neurosurg 1989;70:691-700.
19. Badhe PB, Chauhan PP, Mehta NK. Brainstem gliomas: A clinico-pathological study of 45 cases with p53 immunohistochemistry. Indian J Cancer 2004;41:170-4.
20. Donaldson SS, Laningham F, Fisher PG. Advances toward an understanding of Brainstem Gliomas. J Clin Oncol 2006;24:1266-72.
21. Broniscer A, Iacono L, Chintagumpala M, Fouladi M, Wallace D, Bowers DC, et al. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: Results of a multiinstitutional study (SJHG-98). Cancer 2005;103:133-9.
22. Taphoorn MJ, van den Bent MJ, Mauer ME, Coens C, Delattre JY, Brandes AA, et al. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: Results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol 2007;25:5723-30.
23. Jalali R, Dutta D, Kamble R, Gupta T, Munshi A, Sarin R, et al. Prospective assessment of activities of daily living using Modifed Barthel's Index in children and young adults with low-grade gliomas treated with stereotactic conformal radiotherapy. J Neurooncol 2008;90:321-8.